Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


USP Supplement Monograph Revisions Opposed By Trade Groups

This article was originally published in The Tan Sheet

Executive Summary

The U.S. Pharmacopeia should adopt a flexible approach to nutritional supplement potency limits allowing for variations based on analytical methods, rather than set a minimum 100% limit, the Consumer Healthcare Products Association maintains.

You may also be interested in...

100% Potency Standard For "Added" Supplement Ingredients Upheld By FDA

A substance "intentionally introduced" into a dietary supplement in an amount determined by a manufacturer must meet a 100% potency standard for the product's shelf life, FDA says in an Oct. 19 letter denying an industry petition for a 90% shelf life labeled potency minimum.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts